| NDC Code | 50242-109-01 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-109-01) / 13.4 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 50242-109 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Rituxan Hycela |
|---|
| Non-Proprietary Name | Rituximab And Hyaluronidase |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20170622 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761064 |
|---|
| Manufacturer | Genentech, Inc. |
|---|
| Substance Name | HYALURONIDASE (HUMAN RECOMBINANT); RITUXIMAB |
|---|
| Strength | 2000; 120 |
|---|
| Strength Unit | U/mL; mg/mL |
|---|
| Pharmacy Classes | CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC], Endoglycosidase [EPC], Glycoside Hydrolases [CS] |
|---|